Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Milgrom

Concepts (334)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
31
2023
121
8.630
 Why?
Positron Emission Tomography Computed Tomography
14
2023
67
3.040
 Why?
Radiotherapy, Intensity-Modulated
14
2019
124
2.480
 Why?
Fluorodeoxyglucose F18
7
2023
115
2.370
 Why?
Antineoplastic Combined Chemotherapy Protocols
28
2023
1356
2.210
 Why?
Radiotherapy
12
2020
175
1.960
 Why?
Lymphoma
8
2021
176
1.950
 Why?
Central Nervous System Neoplasms
9
2021
125
1.950
 Why?
Radiation Injuries
8
2021
128
1.880
 Why?
Radiopharmaceuticals
6
2023
158
1.790
 Why?
Neoplasm Staging
30
2021
1162
1.570
 Why?
Radiotherapy Planning, Computer-Assisted
11
2021
117
1.520
 Why?
Tumor Burden
5
2023
258
1.500
 Why?
Neoplasm Recurrence, Local
13
2023
850
1.450
 Why?
Lymphoma, Non-Hodgkin
5
2020
70
1.430
 Why?
Sarcoma
2
2023
137
1.400
 Why?
Lymphoma, Large B-Cell, Diffuse
7
2021
97
1.310
 Why?
Salvage Therapy
10
2020
127
1.260
 Why?
Endometrial Neoplasms
4
2014
141
1.250
 Why?
Mediastinal Neoplasms
5
2021
32
1.210
 Why?
Radiotherapy Dosage
15
2021
243
1.160
 Why?
Combined Modality Therapy
21
2021
1117
1.100
 Why?
Prognosis
22
2023
3315
1.070
 Why?
Hematopoietic Stem Cell Transplantation
6
2023
519
1.040
 Why?
Positron-Emission Tomography
7
2023
260
0.950
 Why?
Radiation
2
2020
24
0.870
 Why?
Adenocarcinoma
3
2014
787
0.860
 Why?
Radiation Exposure
1
2023
41
0.860
 Why?
Radiotherapy, Adjuvant
6
2019
182
0.850
 Why?
Humans
99
2023
114045
0.830
 Why?
Lymphoma, Follicular
5
2020
34
0.810
 Why?
Rhabdomyosarcoma
1
2023
56
0.790
 Why?
Sarcoma, Ewing
1
2023
65
0.780
 Why?
Smiling
1
2021
6
0.780
 Why?
Salivary Glands
2
2021
31
0.780
 Why?
Xerostomia
1
2021
19
0.750
 Why?
Tooth Abnormalities
1
2021
12
0.750
 Why?
Retrospective Studies
36
2023
12521
0.750
 Why?
Aged
41
2020
18969
0.730
 Why?
Brachytherapy
1
2021
100
0.720
 Why?
Chemoradiotherapy
9
2021
187
0.710
 Why?
Middle Aged
48
2020
26605
0.700
 Why?
Neoplasms
3
2023
2086
0.700
 Why?
Proton Therapy
1
2020
10
0.700
 Why?
Aged, 80 and over
21
2020
6306
0.700
 Why?
Face
1
2021
163
0.690
 Why?
Doxorubicin
12
2020
286
0.680
 Why?
Intraocular Lymphoma
2
2016
2
0.660
 Why?
Adult
50
2023
30375
0.660
 Why?
Young Adult
29
2023
10444
0.640
 Why?
Rectal Neoplasms
3
2016
122
0.640
 Why?
Bleomycin
8
2020
228
0.630
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
11
0.620
 Why?
Cerebellar Neoplasms
1
2020
130
0.620
 Why?
Medulloblastoma
1
2020
172
0.600
 Why?
Vinblastine
8
2020
63
0.600
 Why?
Dacarbazine
8
2020
99
0.590
 Why?
Recurrence
9
2020
925
0.580
 Why?
Cancer Survivors
1
2021
205
0.570
 Why?
Leukemia, Myeloid, Acute
2
2023
533
0.560
 Why?
Head and Neck Neoplasms
1
2021
427
0.550
 Why?
Meningeal Neoplasms
1
2018
86
0.550
 Why?
Brain Neoplasms
3
2023
966
0.540
 Why?
Patient Satisfaction
1
2020
571
0.540
 Why?
Leukemia, Biphenotypic, Acute
1
2016
3
0.540
 Why?
Breast Neoplasms
5
2019
1846
0.540
 Why?
Female
54
2020
59324
0.510
 Why?
Treatment Outcome
24
2020
9049
0.510
 Why?
Eye Diseases
1
2016
74
0.490
 Why?
Survival Rate
12
2021
1638
0.490
 Why?
Child
14
2023
18401
0.480
 Why?
Follow-Up Studies
15
2020
4392
0.470
 Why?
Glycolysis
3
2023
224
0.460
 Why?
Graft vs Host Disease
1
2016
212
0.460
 Why?
Male
48
2021
55396
0.460
 Why?
Disease-Free Survival
12
2020
618
0.450
 Why?
Stomach Neoplasms
3
2019
65
0.450
 Why?
Endometrium
1
2013
60
0.430
 Why?
Peritoneal Cavity
1
2013
23
0.430
 Why?
Digestive System Surgical Procedures
1
2014
91
0.430
 Why?
Lymphoma, B-Cell
3
2021
87
0.420
 Why?
Neoadjuvant Therapy
2
2016
305
0.420
 Why?
Palate, Hard
1
2012
4
0.420
 Why?
Infertility, Female
1
2013
93
0.410
 Why?
Disease Progression
6
2019
2371
0.410
 Why?
Chemoradiotherapy, Adjuvant
3
2019
40
0.410
 Why?
Mastectomy, Simple
1
2012
1
0.400
 Why?
Image Enhancement
1
2013
158
0.400
 Why?
Adolescent
21
2023
17800
0.390
 Why?
Carcinoma, Lobular
1
2012
44
0.380
 Why?
Sentinel Lymph Node Biopsy
1
2012
99
0.380
 Why?
Carcinoma, Ductal, Breast
1
2012
76
0.380
 Why?
Adrenal Gland Neoplasms
1
2012
81
0.370
 Why?
Organs at Risk
3
2020
30
0.360
 Why?
Tomography, X-Ray Computed
7
2023
2272
0.360
 Why?
Disease Management
6
2019
556
0.350
 Why?
Biopsy
6
2020
1024
0.340
 Why?
Radiotherapy, Image-Guided
3
2019
30
0.330
 Why?
Cellulitis
1
2009
45
0.330
 Why?
Carcinoma, Squamous Cell
1
2014
577
0.320
 Why?
Kaplan-Meier Estimate
7
2020
813
0.310
 Why?
Lymphocytes
3
2020
327
0.310
 Why?
Lymphoma, Mantle-Cell
2
2019
18
0.300
 Why?
Multiple Myeloma
2
2020
98
0.300
 Why?
Survival Analysis
6
2020
1206
0.270
 Why?
Cardiotoxicity
2
2023
27
0.270
 Why?
Pregnancy Complications, Neoplastic
2
2017
51
0.270
 Why?
Patient Selection
2
2022
629
0.270
 Why?
Testicular Neoplasms
2
2018
96
0.260
 Why?
Radiation Pneumonitis
2
2016
24
0.260
 Why?
Magnetic Resonance Imaging
4
2019
3039
0.250
 Why?
Risk Assessment
6
2023
2958
0.250
 Why?
Heart
3
2018
613
0.250
 Why?
Lymph Node Excision
2
2019
140
0.250
 Why?
Antimetabolites, Antineoplastic
2
2017
80
0.240
 Why?
Leukemia
2
2017
208
0.240
 Why?
Risk Factors
5
2021
8614
0.240
 Why?
Central Nervous System
3
2021
230
0.230
 Why?
Mediastinum
3
2019
20
0.230
 Why?
Consensus
2
2023
532
0.220
 Why?
Lymphatic Metastasis
3
2014
275
0.220
 Why?
Postoperative Complications
1
2014
2122
0.220
 Why?
Lymphadenopathy
1
2023
7
0.220
 Why?
Neoplasm Grading
4
2019
241
0.210
 Why?
Remission Induction
3
2018
233
0.210
 Why?
Protons
2
2020
73
0.200
 Why?
Survivors
2
2023
412
0.200
 Why?
Transplantation, Autologous
3
2018
175
0.200
 Why?
Chemotherapy, Adjuvant
2
2013
332
0.200
 Why?
Brain Stem Neoplasms
1
2023
84
0.200
 Why?
Radiometry
2
2019
41
0.190
 Why?
Gastric Mucosa
2
2019
46
0.190
 Why?
Multimodal Imaging
3
2017
89
0.190
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
15
0.190
 Why?
Poly(ADP-ribose) Polymerases
1
2021
87
0.190
 Why?
Radium
1
2020
3
0.180
 Why?
Breath Holding
2
2017
6
0.180
 Why?
Long Term Adverse Effects
1
2020
10
0.180
 Why?
Cranial Irradiation
2
2023
66
0.180
 Why?
Whole-Body Irradiation
1
2020
72
0.170
 Why?
Stem Cell Transplantation
2
2018
148
0.170
 Why?
Skin Neoplasms
2
2018
754
0.170
 Why?
Cardiology
1
2022
260
0.170
 Why?
Child, Preschool
4
2023
9114
0.170
 Why?
Postoperative Care
2
2019
223
0.170
 Why?
Glioma
1
2023
285
0.170
 Why?
Radiation Dosage
1
2020
133
0.160
 Why?
Plasmacytoma
1
2019
9
0.160
 Why?
CD4-CD8 Ratio
1
2018
19
0.160
 Why?
Mycosis Fungoides
1
2018
60
0.160
 Why?
Methotrexate
2
2017
227
0.160
 Why?
Peritoneal Neoplasms
1
2019
54
0.150
 Why?
Electrons
1
2018
71
0.150
 Why?
Area Under Curve
1
2019
273
0.150
 Why?
Breast Neoplasms, Male
1
2018
28
0.150
 Why?
Radiotherapy Setup Errors
1
2017
3
0.150
 Why?
Autografts
1
2018
40
0.150
 Why?
Platelet Count
1
2017
79
0.150
 Why?
Hypothyroidism
1
2018
65
0.140
 Why?
Craniospinal Irradiation
1
2017
4
0.140
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
2
0.140
 Why?
Vincristine
4
2019
98
0.140
 Why?
Eye Neoplasms
1
2017
14
0.140
 Why?
Uncertainty
1
2017
91
0.140
 Why?
Leukocyte Count
1
2017
292
0.140
 Why?
Predictive Value of Tests
3
2022
1791
0.140
 Why?
Spinal Cord Diseases
1
2017
38
0.140
 Why?
Neoplasm, Residual
1
2017
104
0.140
 Why?
Osteogenesis Imperfecta
2
2007
13
0.140
 Why?
Pentostatin
1
2016
1
0.140
 Why?
Axilla
2
2017
39
0.140
 Why?
Photopheresis
1
2016
9
0.130
 Why?
Anxiety
1
2023
843
0.130
 Why?
Drug Resistance, Neoplasm
2
2019
636
0.130
 Why?
Collagen Type I
2
2007
108
0.130
 Why?
Methylprednisolone
1
2016
80
0.130
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
98
0.130
 Why?
Plasmablastic Lymphoma
1
2015
6
0.130
 Why?
Confidence Intervals
1
2016
302
0.130
 Why?
Antibiotics, Antineoplastic
1
2016
110
0.130
 Why?
Congenital Abnormalities
1
2016
72
0.130
 Why?
Abortion, Spontaneous
1
2016
89
0.130
 Why?
Fatal Outcome
1
2016
281
0.130
 Why?
Hysterectomy
2
2013
105
0.130
 Why?
Biomarkers
4
2021
3397
0.130
 Why?
Coronary Artery Disease
1
2021
611
0.130
 Why?
Tacrolimus
1
2016
134
0.120
 Why?
Proportional Hazards Models
4
2020
1078
0.120
 Why?
Transplantation, Homologous
1
2016
377
0.120
 Why?
Blood Platelets
1
2017
326
0.120
 Why?
Age Factors
1
2021
2885
0.110
 Why?
Antineoplastic Agents
4
2019
1875
0.110
 Why?
Risk
1
2016
810
0.110
 Why?
Caregivers
1
2020
713
0.110
 Why?
Kidney Neoplasms
1
2018
324
0.110
 Why?
Receptors, Progesterone
2
2014
319
0.110
 Why?
Etoposide
3
2018
149
0.110
 Why?
Receptor, ErbB-2
2
2014
300
0.110
 Why?
Cyclophosphamide
3
2019
214
0.110
 Why?
Lung
2
2016
3521
0.110
 Why?
Rituximab
3
2019
148
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
959
0.110
 Why?
Spinal Cord
1
2015
344
0.110
 Why?
Receptors, Estrogen
2
2014
371
0.110
 Why?
Carboplatin
1
2013
135
0.100
 Why?
Anti-Inflammatory Agents
1
2016
445
0.100
 Why?
Neutrophils
1
2017
1089
0.100
 Why?
Fluorouracil
1
2013
152
0.100
 Why?
Pelvis
1
2013
89
0.100
 Why?
Radiotherapy, Conformal
1
2012
68
0.100
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1168
0.100
 Why?
Immunosuppressive Agents
1
2016
641
0.100
 Why?
Paclitaxel
1
2013
190
0.100
 Why?
Brain
2
2020
2355
0.100
 Why?
Cisplatin
1
2013
262
0.100
 Why?
Immunohistochemistry
1
2016
1624
0.100
 Why?
Immunoenzyme Techniques
1
2012
192
0.100
 Why?
Immunotherapy
1
2015
473
0.100
 Why?
Triple Negative Breast Neoplasms
1
2014
157
0.100
 Why?
Models, Biological
1
2018
1611
0.090
 Why?
Contrast Media
1
2013
347
0.090
 Why?
Liver Neoplasms
1
2014
504
0.090
 Why?
Cohort Studies
5
2018
4883
0.090
 Why?
Prospective Studies
3
2021
6195
0.090
 Why?
Polymorphism, Single Nucleotide
1
2016
1880
0.080
 Why?
Patient Compliance
1
2013
524
0.080
 Why?
Lung Neoplasms
1
2021
2159
0.080
 Why?
Dose-Response Relationship, Radiation
2
2020
127
0.080
 Why?
United States
2
2021
12137
0.080
 Why?
Colorectal Neoplasms
1
2014
592
0.070
 Why?
Biomarkers, Tumor
1
2014
1032
0.070
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
82
0.070
 Why?
Prednisone
2
2019
229
0.070
 Why?
Practice Guidelines as Topic
1
2014
1381
0.070
 Why?
Time Factors
4
2018
6077
0.070
 Why?
Cytarabine
2
2018
51
0.070
 Why?
Integrins
1
2007
80
0.070
 Why?
Proteoglycans
1
2007
107
0.070
 Why?
Treatment Failure
2
2018
330
0.060
 Why?
Glycine
1
2006
152
0.060
 Why?
Clinical Decision-Making
2
2019
268
0.060
 Why?
Amino Acid Substitution
1
2006
261
0.060
 Why?
Neoplasm Invasiveness
2
2017
438
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
14
0.060
 Why?
Intelligence Tests
1
2023
57
0.060
 Why?
X-Rays
1
2023
30
0.050
 Why?
Phenotype
3
2021
2784
0.050
 Why?
Regression Analysis
2
2016
945
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
33
0.050
 Why?
Analysis of Variance
2
2016
1218
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
9
0.050
 Why?
Cytidine Deaminase
1
2023
57
0.050
 Why?
Brain Stem
1
2023
94
0.050
 Why?
Ribose
1
2021
18
0.050
 Why?
Adenosine Diphosphate
1
2021
76
0.050
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
40
0.050
 Why?
Troponin T
1
2021
49
0.050
 Why?
Feedback
1
2021
144
0.050
 Why?
Prevalence
2
2016
2247
0.040
 Why?
Automation
1
2020
74
0.040
 Why?
Neoplasms, Radiation-Induced
1
2020
66
0.040
 Why?
Incidence
2
2016
2314
0.040
 Why?
Neuropsychological Tests
1
2023
926
0.040
 Why?
Risk Management
1
2020
89
0.040
 Why?
Workflow
1
2020
132
0.040
 Why?
Neoplasms, Second Primary
1
2020
92
0.040
 Why?
Mesentery
1
2019
41
0.040
 Why?
Safety
1
2020
298
0.040
 Why?
Busulfan
1
2018
14
0.040
 Why?
Melphalan
1
2018
29
0.040
 Why?
Respiration
1
2019
180
0.040
 Why?
Carmustine
1
2018
47
0.040
 Why?
Time-to-Treatment
1
2019
146
0.040
 Why?
Cone-Beam Computed Tomography
1
2017
24
0.040
 Why?
Inhalation
1
2017
26
0.040
 Why?
Breast
1
2018
138
0.040
 Why?
Phosphorylation
1
2021
1558
0.040
 Why?
Subacute Combined Degeneration
1
2017
1
0.040
 Why?
Deoxycytidine
1
2018
138
0.030
 Why?
Photons
1
2017
57
0.030
 Why?
Organ Sparing Treatments
1
2017
31
0.030
 Why?
Injections, Spinal
1
2017
101
0.030
 Why?
Orbit
1
2017
52
0.030
 Why?
Lymph Nodes
1
2019
415
0.030
 Why?
New York
1
2016
105
0.030
 Why?
Animals
2
2021
31565
0.030
 Why?
Mutation
1
2007
3338
0.030
 Why?
Homocysteine
1
2017
137
0.030
 Why?
Mitochondria
1
2021
744
0.030
 Why?
Procarbazine
1
2015
8
0.030
 Why?
Observer Variation
1
2016
298
0.030
 Why?
Transforming Growth Factor beta1
1
2016
153
0.030
 Why?
Folic Acid
1
2017
161
0.030
 Why?
Genetic Markers
1
2016
320
0.030
 Why?
Texas
1
2016
188
0.030
 Why?
Pregnancy
2
2017
5499
0.030
 Why?
Molecular Targeted Therapy
1
2018
347
0.030
 Why?
Abortion, Induced
1
2016
71
0.030
 Why?
Pregnancy Outcome
1
2017
337
0.030
 Why?
Gastrointestinal Diseases
1
2016
182
0.030
 Why?
Diagnostic Imaging
1
2017
278
0.030
 Why?
Secondary Prevention
1
2016
221
0.030
 Why?
Drug Administration Schedule
1
2016
714
0.030
 Why?
Acute Disease
1
2016
907
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
256
0.030
 Why?
Postpartum Period
1
2016
275
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2018
686
0.030
 Why?
Mastectomy
1
2014
99
0.030
 Why?
Ultrasonography
1
2016
635
0.030
 Why?
CD4-Positive T-Lymphocytes
1
2018
959
0.030
 Why?
Diagnosis, Differential
1
2017
1331
0.030
 Why?
Multivariate Analysis
1
2016
1422
0.030
 Why?
Medical Oncology
1
2014
229
0.030
 Why?
Ovariectomy
1
2012
116
0.030
 Why?
Comorbidity
1
2016
1447
0.020
 Why?
Severity of Illness Index
1
2019
2537
0.020
 Why?
Quality of Life
1
2021
2343
0.020
 Why?
Electronic Health Records
1
2017
799
0.020
 Why?
Kidney
1
2017
1182
0.020
 Why?
Diet
1
2017
1080
0.020
 Why?
Anti-Bacterial Agents
1
2019
1471
0.020
 Why?
Reproducibility of Results
1
2016
2764
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2090
0.020
 Why?
Infant
1
2020
7943
0.020
 Why?
Case-Control Studies
1
2014
3003
0.020
 Why?
Electrophoresis
1
2006
26
0.020
 Why?
DNA Mutational Analysis
1
2007
373
0.020
 Why?
Databases, Genetic
1
2007
206
0.020
 Why?
Mice
1
2021
14843
0.020
 Why?
Collagen
1
2007
414
0.010
 Why?
Protein Structure, Tertiary
1
2007
796
0.010
 Why?
Binding Sites
1
2007
1166
0.010
 Why?
Protein Binding
1
2007
1888
0.010
 Why?
Cells, Cultured
1
2006
3861
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (334) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)